News
GNNSF
4.500
NaN%
--
Weekly Report: what happened at GNNSF last week (1109-1113)?
Weekly Report · 4d ago
Morgan Stanley Sticks to Their Buy Rating for Genscript Biotech (GNNSF)
TipRanks · 6d ago
Genscript Discloses Legend Biotech Third-Quarter 2026 Results
TipRanks · 11/10 12:39
Weekly Report: what happened at GNNSF last week (1102-1106)?
Weekly Report · 11/09 10:14
Legend Biotech to Present Cell-Therapy Data at ASH 2026
TipRanks · 11/04 23:42
GenScript Clarifies Trading-Counter Change Amid Share-Price Volatility
TipRanks · 11/03 11:09
Weekly Report: what happened at GNNSF last week (1026-1030)?
Weekly Report · 11/02 10:13
GenScript Biotech Reports Death of Company Secretary
TipRanks · 11/02 09:08
Morgan Stanley Sticks to Their Buy Rating for Genscript Biotech (GNNSF)
TipRanks · 10/31 02:25
Weekly Report: what happened at GNNSF last week (1019-1023)?
Weekly Report · 10/26 10:13
Weekly Report: what happened at GNNSF last week (1012-1016)?
Weekly Report · 10/19 10:13
Legend Biotech Posts US$710 Million Quarterly Sales for CARVYKTI
TipRanks · 10/13 12:37
Weekly Report: what happened at GNNSF last week (1005-1009)?
Weekly Report · 10/12 10:18
Weekly Report: what happened at GNNSF last week (0928-1002)?
Weekly Report · 10/05 10:18
Weekly Report: what happened at GNNSF last week (0921-0925)?
Weekly Report · 09/28 10:13
Weekly Report: what happened at GNNSF last week (0914-0918)?
Weekly Report · 09/21 10:13
Genscript Biotech Halves Trading Lot Size to Boost Liquidity on Hong Kong Market
TipRanks · 09/21 09:39
CSC Financial Sticks to Its Buy Rating for Genscript Biotech (GNNSF)
TipRanks · 09/18 08:25
Analysts Are Bullish on Top Healthcare Stocks: LifeMD (LFMD), Genscript Biotech (GNNSF)
TipRanks · 09/17 16:00
Genscript Biotech Joins Lilly’s AI Drug Discovery Platform Amid Share Price Surge
TipRanks · 09/17 15:08
More
Webull provides a variety of real-time GNNSF stock news. You can receive the latest news about Genscript Biotec through multiple platforms. This information may help you make smarter investment decisions.
About GNNSF
Genscript Biotech Corp is an investment holding company principally engaged in the manufacture and sale of life science research products and services. The Company operates its businesses through five segments. The Life-science Services and Products segment provides comprehensive research services and products. The Biologics Development Services segment provides comprehensive services to help biopharmaceutical and biotech companies accelerate the development of therapeutic antibodies, and gene, cell therapy products with an integrated platform. The Industrial Synthetic Biology Products segment provides industrial enzyme development and production through non-pathogenic microbial strains constructed using genetic engineering. The Cell Therapy segment discovers and develops CAR-T therapies for the treatment of liquid and solid tumors. The Operation segment provides shared services to other segments. The Company mainly operates its businesses in the domestic and overseas markets.